Bone Biologics Corp - ESG Rating & Company Profile powered by AI
This webpage of Bone Biologics Corp was assembled by All Street Sevva using advanced AI. This webpage contains a zero-cost ESG assessment for Bone Biologics Corp. This SDG rating for Bone Biologics Corp indicates its reporting of the United Nations SDGs.
Bone Biologics Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | Bone Biologics Corp | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bone Biologics Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bone Biologics Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Bone Biologics Corp report the average age of the workforce?
Sign up for free to unlockDoes Bone Biologics Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bone Biologics Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bone Biologics Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Bone Biologics Corp offer flexible work?
Sign up for free to unlockDoes Bone Biologics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bone Biologics Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bone Biologics Corp conduct supply chain audits?
Sign up for free to unlockDoes Bone Biologics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bone Biologics Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bone Biologics Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bone Biologics Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bone Biologics Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bone Biologics Corp disclose water use targets?
Sign up for free to unlockDoes Bone Biologics Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Bone Biologics Corp have a product recall in the last two years?
Sign up for free to unlockDoes Bone Biologics Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Bone Biologics Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bone Biologics Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bone Biologics Corp disclose parental leave metrics?
Sign up for free to unlockDoes Bone Biologics Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bone Biologics Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bone Biologics Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bone Biologics Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bone Biologics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bone Biologics Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bone Biologics Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Bone Biologics Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bone Biologics Corp disclose its waste policy?
Sign up for free to unlockDoes Bone Biologics Corp report according to TCFD requirements?
Sign up for free to unlockDoes Bone Biologics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bone Biologics Corp disclose energy use targets?
Sign up for free to unlockDoes Bone Biologics Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bone Biologics Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bone Biologics Corp
These potential risks are based on the size, segment and geographies of the company.
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.